{"id":"https://openalex.org/W1968677495","doi":"https://doi.org/10.1097/00001813-200101000-00008","title":"Evaluation of combretastatin A-4 prodrug in a non-Hodgkin\u2019s lymphoma xenograft model: preclinical efficacy","display_name":"Evaluation of combretastatin A-4 prodrug in a non-Hodgkin\u2019s lymphoma xenograft model: preclinical efficacy","publication_year":2001,"publication_date":"2001-01-01","ids":{"openalex":"https://openalex.org/W1968677495","doi":"https://doi.org/10.1097/00001813-200101000-00008","mag":"1968677495","pmid":"https://pubmed.ncbi.nlm.nih.gov/11272287"},"language":"en","primary_location":{"id":"doi:10.1097/00001813-200101000-00008","doi":"https://doi.org/10.1097/00001813-200101000-00008","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00001813-200101000-00008","pdf_url":null,"source":{"id":"https://openalex.org/S158028025","display_name":"Anti-Cancer Drugs","issn_l":"0959-4973","issn":["0959-4973","1473-5741"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-Cancer Drugs","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1968677495"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5022477585","display_name":"Sanaa M. Nabha","orcid":"https://orcid.org/0000-0002-6578-872X","observed_orcids":["https://orcid.org/0000-0002-6578-872X"]},"institutions":[{"id":"https://openalex.org/I185443292","display_name":"Wayne State University","ror":"https://ror.org/01070mq45","country_code":"US","type":"education","lineage":["https://openalex.org/I185443292"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sanaa M Nabha","raw_affiliation_strings":["Department of Internal Medicine, Wayne State University, School of Medicine, Detroit, MI 48201, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Wayne State University, School of Medicine, Detroit, MI 48201, USA","institution_ids":["https://openalex.org/I185443292"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011312785","display_name":"Ramzi M. Mohammad","orcid":"https://orcid.org/0000-0003-0232-9101","observed_orcids":["https://orcid.org/0000-0003-0232-9101"]},"institutions":[{"id":"https://openalex.org/I185443292","display_name":"Wayne State University","ror":"https://ror.org/01070mq45","country_code":"US","type":"education","lineage":["https://openalex.org/I185443292"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ramzi M Mohammad","raw_affiliation_strings":["Division of Hematology and Oncology, Department of Internal Medicine, Wayne State University, School of Medicine, Detroit, MI 48201, USA","Wayne State University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Oncology, Department of Internal Medicine, Wayne State University, School of Medicine, Detroit, MI 48201, USA","institution_ids":["https://openalex.org/I185443292"]},{"raw_affiliation_string":"Wayne State University","institution_ids":["https://openalex.org/I185443292"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040623212","display_name":"Nathan R. Wall","orcid":"https://orcid.org/0000-0002-3235-4386","observed_orcids":["https://orcid.org/0000-0002-3235-4386"]},"institutions":[{"id":"https://openalex.org/I185443292","display_name":"Wayne State University","ror":"https://ror.org/01070mq45","country_code":"US","type":"education","lineage":["https://openalex.org/I185443292"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nathan R Wall","raw_affiliation_strings":["Division of Hematology and Oncology, Department of Internal Medicine, Wayne State University, School of Medicine, Detroit, MI 48201, USA","Wayne State University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Oncology, Department of Internal Medicine, Wayne State University, School of Medicine, Detroit, MI 48201, USA","institution_ids":["https://openalex.org/I185443292"]},{"raw_affiliation_string":"Wayne State University","institution_ids":["https://openalex.org/I185443292"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060776695","display_name":"Julie A. Dutcher","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I185443292","display_name":"Wayne State University","ror":"https://ror.org/01070mq45","country_code":"US","type":"education","lineage":["https://openalex.org/I185443292"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Julie A Dutcher","raw_affiliation_strings":["Division of Hematology and Oncology, Department of Internal Medicine, Wayne State University, School of Medicine, Detroit, MI 48201, USA","Wayne State University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Oncology, Department of Internal Medicine, Wayne State University, School of Medicine, Detroit, MI 48201, USA","institution_ids":["https://openalex.org/I185443292"]},{"raw_affiliation_string":"Wayne State University","institution_ids":["https://openalex.org/I185443292"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007414440","display_name":"Bashar M Salkini","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I185443292","display_name":"Wayne State University","ror":"https://ror.org/01070mq45","country_code":"US","type":"education","lineage":["https://openalex.org/I185443292"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bashar M Salkini","raw_affiliation_strings":["Division of Hematology and Oncology, Department of Internal Medicine, Wayne State University, School of Medicine, Detroit, MI 48201, USA","Wayne State University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Oncology, Department of Internal Medicine, Wayne State University, School of Medicine, Detroit, MI 48201, USA","institution_ids":["https://openalex.org/I185443292"]},{"raw_affiliation_string":"Wayne State University","institution_ids":["https://openalex.org/I185443292"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066809993","display_name":"George R. Pettit","orcid":"https://orcid.org/0000-0001-8706-8929","observed_orcids":["https://orcid.org/0000-0001-8706-8929"]},"institutions":[{"id":"https://openalex.org/I55732556","display_name":"Arizona State University","ror":"https://ror.org/03efmqc40","country_code":"US","type":"education","lineage":["https://openalex.org/I55732556"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"George R Pettit","raw_affiliation_strings":["Cancer Research Institute and Department of Chemistry and Biochemistry, Arizona State University, Tempe, AZ 85287-1604, USA","CLAS-NS: Molecular Sciences, School of (SMS)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Research Institute and Department of Chemistry and Biochemistry, Arizona State University, Tempe, AZ 85287-1604, USA","institution_ids":["https://openalex.org/I55732556"]},{"raw_affiliation_string":"CLAS-NS: Molecular Sciences, School of (SMS)","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5065296584","display_name":"Ayad M Al-Katib","orcid":"https://orcid.org/0000-0002-5684-948X","observed_orcids":["https://orcid.org/0000-0002-5684-948X"]},"institutions":[{"id":"https://openalex.org/I185443292","display_name":"Wayne State University","ror":"https://ror.org/01070mq45","country_code":"US","type":"education","lineage":["https://openalex.org/I185443292"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Ayad M Al-Katib","raw_affiliation_strings":["Division of Hematology and Oncology, Department of Internal Medicine, Wayne State University, School of Medicine, Detroit, MI 48201, USA","Wayne State University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Oncology, Department of Internal Medicine, Wayne State University, School of Medicine, Detroit, MI 48201, USA","institution_ids":["https://openalex.org/I185443292"]},{"raw_affiliation_string":"Wayne State University","institution_ids":["https://openalex.org/I185443292"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5065296584"],"corresponding_institution_ids":["https://openalex.org/I185443292"],"apc_list":null,"apc_paid":null,"fwci":0.2864,"has_fulltext":false,"cited_by_count":26,"citation_normalized_percentile":{"value":0.45737163,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"12","issue":"1","first_page":"57","last_page":"63"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.9136000275611877,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.9136000275611877,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.020899999886751175,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11469","display_name":"Lymphatic System and Diseases","score":0.014100000262260437,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/non-hodgkin-lymphoma","display_name":"non-Hodgkin lymphoma","score":0.9570000171661377},{"id":"https://openalex.org/keywords/diffuse-large-cell-lymphoma","display_name":"diffuse large cell lymphoma","score":0.9789999723434448},{"id":"https://openalex.org/keywords/antiangiogenic-activity","display_name":"antiangiogenic activity","score":0.8840000033378601},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.9089999794960022},{"id":"https://openalex.org/keywords/dose-scheduling","display_name":"dose scheduling","score":0.5809999704360962},{"id":"https://openalex.org/keywords/tumor-necrosis","display_name":"tumor necrosis","score":0.6000000238418579},{"id":"https://openalex.org/keywords/g2-m-cell-cycle-arrest","display_name":"G2/M cell cycle arrest","score":0.7590000033378601}],"concepts":[{"id":"https://openalex.org/C108215921","wikidata":"https://www.wikidata.org/wiki/Q603741","display_name":"Prodrug","level":2,"score":0.7420381307601929},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.7325171232223511},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.6367213726043701},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.5917681455612183},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5290115475654602},{"id":"https://openalex.org/C204232928","wikidata":"https://www.wikidata.org/wiki/Q899285","display_name":"Immunohistochemistry","level":2,"score":0.48805344104766846},{"id":"https://openalex.org/C2778939058","wikidata":"https://www.wikidata.org/wiki/Q4046167","display_name":"CD31","level":3,"score":0.4359336495399475},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.42914876341819763},{"id":"https://openalex.org/C2778275628","wikidata":"https://www.wikidata.org/wiki/Q5150954","display_name":"Combretastatin","level":4,"score":0.4166696071624756},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.4163736402988434},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.336211234331131},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.24713736772537231},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.16211777925491333},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.04980096220970154},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C20418707","wikidata":"https://www.wikidata.org/wiki/Q189933","display_name":"Microtubule","level":2,"score":0.0},{"id":"https://openalex.org/C84425145","wikidata":"https://www.wikidata.org/wiki/Q422492","display_name":"Tubulin","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000972","descriptor_name":"Antineoplastic Agents, Phytogenic","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000972","descriptor_name":"Antineoplastic Agents, Phytogenic","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002453","descriptor_name":"Cell Cycle","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008228","descriptor_name":"Lymphoma, Non-Hodgkin","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008228","descriptor_name":"Lymphoma, Non-Hodgkin","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008813","descriptor_name":"Mice, Inbred ICR","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009389","descriptor_name":"Neovascularization, Pathologic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D011355","descriptor_name":"Prodrugs","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011355","descriptor_name":"Prodrugs","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D013267","descriptor_name":"Stilbenes","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D013267","descriptor_name":"Stilbenes","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D015996","descriptor_name":"Survival Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016513","descriptor_name":"Mice, SCID","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020714","descriptor_name":"Maximum Tolerated Dose","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/00001813-200101000-00008","doi":"https://doi.org/10.1097/00001813-200101000-00008","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00001813-200101000-00008","pdf_url":null,"source":{"id":"https://openalex.org/S158028025","display_name":"Anti-Cancer Drugs","issn_l":"0959-4973","issn":["0959-4973","1473-5741"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-Cancer Drugs","raw_type":"journal-article"},{"id":"pmid:11272287","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11272287","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-cancer drugs","raw_type":"Evaluation Study"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9907000064849854,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G4720276181","display_name":"OUTSTANDING INVESTIGATOR","funder_award_id":"R35CA044344","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G5932337109","display_name":null,"funder_award_id":"CA44344-10-12","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G678883038","display_name":null,"funder_award_id":"P30-CA22453-20","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G8108408337","display_name":"POTENTIATION OF 2CDA ACTIVITY IN CLL BY BRYOSTATIN 1","funder_award_id":"R01CA079837","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000905662","display_name":"CANCER CENTER SUPPORT GRANT","funder_award_id":"P30CA022453","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":24,"referenced_works":["https://openalex.org/W103592546","https://openalex.org/W1579297325","https://openalex.org/W1593154204","https://openalex.org/W1758017998","https://openalex.org/W1943173994","https://openalex.org/W1969328947","https://openalex.org/W1985147506","https://openalex.org/W1994297035","https://openalex.org/W2000000541","https://openalex.org/W2006273356","https://openalex.org/W2008344416","https://openalex.org/W2043297474","https://openalex.org/W2072928113","https://openalex.org/W2077851812","https://openalex.org/W2103396260","https://openalex.org/W2105874877","https://openalex.org/W2123927174","https://openalex.org/W2128796524","https://openalex.org/W2142760959","https://openalex.org/W2151195433","https://openalex.org/W2158743409","https://openalex.org/W2161708429","https://openalex.org/W2294376824","https://openalex.org/W2409982489"],"related_works":["https://openalex.org/W2095463510","https://openalex.org/W2370208190","https://openalex.org/W2001265485","https://openalex.org/W2036761725","https://openalex.org/W2374740109","https://openalex.org/W1991177400","https://openalex.org/W2157808233","https://openalex.org/W2472440478","https://openalex.org/W2076441961","https://openalex.org/W7001213991"],"abstract_inverted_index":{"Combretastatin":[0],"A-4":[1],"prodrug":[2],"(CA4P)":[3],"is":[4],"a":[5,30,127,154,190,215],"new":[6],"antitubulin":[7],"agent":[8,260],"currently":[9],"in":[10,24,51,85,105,118,157,193,206,224,229,242,251,265],"phase":[11],"I/II":[12],"clinical":[13],"trials":[14],"against":[15,29,93],"solid":[16],"tumors.":[17],"We":[18,244],"have":[19],"previously":[20],"reported":[21],"on":[22],"the":[23,43,46,76,158,170,176,184,234,256,266],"vitro":[25,225],"activity":[26,48,92,250],"of":[27,32,49,82,130,133,137,160,172,178,183,195,218,233,258,268],"CA4P":[28,50,77,88,116,247],"panel":[31],"malignant":[33],"human":[34],"B-lymphoid":[35],"cell":[36,55],"lines.":[37],"In":[38],"this":[39,94,252,259],"study,":[40],"we":[41],"investigated":[42],"antitumor":[44,91,240],"and":[45,107,112,135,149,255],"antiangiogenic":[47,235,249],"our":[52],"diffuse":[53],"large":[54],"lymphoma":[56,95,253],"WSU-DLCL2-SCID":[57],"mouse":[58],"model.":[59,96],"WSU-DLCL2":[60],"cells":[61],"(10(7))":[62],"were":[63,73,99],"injected":[64],"s.c.":[65],"into":[66],"5-week-old":[67],"female":[68],"ICR-SCID":[69],"mice.":[70],"Tumor-bearing":[71],"mice":[72],"treated":[74,173],"at":[75],"maximum":[78],"tolerated":[79],"dose":[80,217],"(MTD)":[81],"800":[83],"mg/kg":[84],"different":[86],"dose/schedules.":[87],"showed":[89,126,189],"significant":[90,155],"Best":[97],"results":[98],"seen":[100],"when":[101],"MTD":[102],"was":[103,202,226],"given":[104,117],"two":[106],"four":[108,119],"divided":[109,120],"doses":[110,121],"(400":[111],"200":[113,124],"mg/kg,":[114],"respectively).":[115],"(4":[122],"x":[123],"mg/kg)":[125],"log10":[128],"kill":[129],"1.01,":[131],"T/C":[132],"11.7%":[134],"T-C":[136],"12":[138],"days.":[139],"Immunohistochemical":[140],"staining":[141,188],"using":[142],"anti-CD31":[143],"antibody":[144],"after":[145,164,186],"6,":[146],"24,":[147],"48":[148,212],"120":[150],"h":[151,166,213],"treatment":[152,267],"revealed":[153,175],"decrease":[156],"number":[159],"tumor":[161,207],"blood":[162,179,199],"vessels":[163],"24":[165],"(about":[167],"80%).":[168],"Only":[169],"periphery":[171],"tumors":[174,185,194],"presence":[177],"vessels.":[180],"Morphological":[181],"examination":[182],"tetrachrome":[187],"necrotic":[191],"center":[192],"CA4P-treated":[196],"animals.":[197],"New":[198],"vessel":[200],"formation":[201],"noted":[203],"to":[204,239],"emerge":[205],"tissues":[208],"as":[209,211],"early":[210],"following":[214],"single":[216],"CA4P.":[219],"The":[220],"G2/M":[221],"arrest":[222],"observed":[223],"not":[227],"detected":[228],"vivo":[230],"indicating":[231],"predominance":[232],"effects":[236],"with":[237],"regard":[238],"efficacy":[241],"vivo.":[243],"conclude":[245],"that":[246],"has":[248],"model":[254],"use":[257],"should":[261],"be":[262],"explored":[263],"clinically":[264],"non-Hodgkin's":[269],"lymphoma.":[270]},"counts_by_year":[{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2016-06-24T00:00:00"}